---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-012326"
form_type: "8-K"
ticker: "NAII"
cik: "0000787253"
company_name: "NATURAL ALTERNATIVES INTERNATIONAL INC"
filed_at: "2022-05-13T23:59:59+00:00"
generated_at: "2026-06-25T17:19:34.295646+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NAI Q3 net income up 30.7% to $2.5M; Q4 sales outlook +18-21%

## Summary
- Q3 net sales $42.4M (-8.5% YoY); private-label manufacturing down 10.8% due to 40% drop from largest customer.
- Net income $2.5M ($0.41 EPS) vs $1.9M ($0.30 EPS) YoY, up 30.7% and 36.7% respectively.
- CarnoSyn royalty/license revenue rose 15.2% to $4.8M in Q3; nine-month revenue up 41.7% to $13.5M.
- Q4 FY2022 guidance: net sales +18-21% YoY and operating income margin 9-12%.
- Cash $18.6M, working capital $53.8M; $20M available on credit line.

## SEC filing metadata
- accession: 0001437749-22-012326
- form_type: 8-K
- ticker: NAII
- cik: 0000787253
- company_name: NATURAL ALTERNATIVES INTERNATIONAL INC
- filed_at: 2022-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/787253/000143774922012326/0001437749-22-012326-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/787253/000143774922012326/naii20220512_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-012326
- JSON: https://secwatch.observer/filing/0001437749-22-012326.json
- Plain text: https://secwatch.observer/filing/0001437749-22-012326.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.